Is Nectar Lifesciences stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Nectar Lifesciences pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 21st of September 2020 were paid INR0.05 per share. Over the last 16 times between 2006 and 2020, Nectar Lifesciences has paid INR8.2 with an average of INR0.51 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Nectar Lifesciences 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR14.50, you would have made a profit of INR37.17 per share or 256.34%
Yes, the average daily trading liquidity for Nectar Lifesciences is INR1.69 million. You should therefore be able to get in and out of your positions relatively fast.
Nectar Lifesciences has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.14, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 0.30%, which is challenging.
We have calculated the inflation risk for Nectar Lifesciences to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.